Literature DB >> 18360913

Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003.

Licel de los Angeles Rodríguez Lay1, Ariel Quintana, María Caridad Montalvo Villalba, Gilda Lemos, Marité Bello Corredor, Aidonis Gutiérrez Moreno, Pablo Aguiar Prieto, María G Guzmán, David Anderson.   

Abstract

Viral hepatitis ranks as the fifth cause of morbidity for infectious diseases in Cuba. Epidemics are observed frequently in the population, the hepatitis A virus being the main agent responsible for such epidemics. Previous reports also confirmed the circulation of the hepatitis E virus. From 1998 to 2003, 258 serum samples were collected by the Reference Laboratory on Viral Hepatitis during 33 outbreaks of acute viral hepatitis as well as from 39 sporadic clinical cases. Sera were tested for anti-HAV and anti-HEV IgM by EIA. Overall of the 33 outbreaks studied sera from 12 (36.4%) were positive for anti-HAV IgM only, from 7 (21.2%) were positive for anti-HEV IgM only, and from 14 (42.4%) were positive for antibodies to both viruses. Individually of the 258 sera collected, 137 (53.1%) were positives for anti-HAV IgM, 20 (7.8%) were positives for anti-HEV IgM, 33 (12.8%) were positives for both markers and 68 (26.4%) were negative to both. Of the clinical cases, 4 (10.3%) were positives for anti-HAV IgM, 13 (33.3%) were positives for anti-HEV IgM and 5 (12.8%) were positives for both markers. Seventeen (43.6%) sera were negatives for all viral hepatitis markers available (A-E). A high positivity for HEV was found in outbreaks tested with the kit produced by CIGB. In particular HEV seems to infect individuals of all ages. The results demonstrate the co-circulation of and co-infection with two enterically transmitted viruses; however a higher positivity was observed for anti-HAV than to anti-HEV (53.1% vs. 7.8%) in outbreaks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360913     DOI: 10.1002/jmv.21147

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis.

Authors:  Nathalie Verónica Fernández Villalobos; Barbora Kessel; Isti Rodiah; Jördis Jennifer Ott; Berit Lange; Gérard Krause
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

2.  Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.

Authors:  Osmany Larralde; Juraj Petrik
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

3.  Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France.

Authors:  Barbara Doudier; Hugues Vencatassin; Sarah Aherfi; Philippe Colson
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

4.  Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.

Authors:  Yan Gao; Qiudong Su; Yao Yi; Zhiyuan Jia; Hao Wang; Xuexin Lu; Feng Qiu; Shengli Bi
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Simultaneous infection of Hepatitis A and Hepatitis E viruses amongst acute viral hepatitis patients: A hospital-based study from Uttarakhand.

Authors:  Deepjyoti Kalita; Manisha Paul; Sangeeta Deka; Gaurav Badoni; Pratima Gupta
Journal:  J Family Med Prim Care       Date:  2020-12-31

6.  Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.

Authors:  Julio Rendon; Maria Cristina Hoyos; Diana di Filippo; Fabian Cortes-Mancera; Carolina Mantilla; Maria Mercedes Velasquez; Maria Elsy Sepulveda; Juan Carlos Restrepo; Sergio Jaramillo; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

7.  Hepatitis E virus infection in patients with acute non-A, non-B, non-C hepatitis in Central Brazil.

Authors:  Nara Rubia de Freitas; Edna Braz Rocha de Santana; Ágabo Macedo da Costa E Silva; Sueli Meira da Silva; Sheila Araújo Teles; Noemi Rovaris Gardinali; Marcelo Alves Pinto; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-13       Impact factor: 2.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.